SAGE THERAPEUTICS INC(NASDAQ:SAGE) stock News

SAGE Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: The Motley Fool

Sage (SAGE) Q2 Revenue Jumps 264%

15 days ago - By: Supernus Pharmaceuticals, Inc. - Mentions: SUPN

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics

16 days ago - By: Sage Therapeutics, Inc.

Sage Therapeutics Announces Second Quarter 2025 Financial Results

19 days ago - By: Supernus Pharmaceuticals, Inc. - Mentions: SUPN

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

a month ago - By: Benzinga

Beyond The Numbers: 6 Analysts Discuss Sage Therapeutics Stock

2 months ago - By: Benzinga

Deep Dive Into Sage Therapeutics Stock: Analyst Perspectives (4 Ratings)

22 days ago - By: Biogen Inc. - Mentions: BIIB

ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression

a month ago - By: Kahn Swick & Foti, LLC

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

2 months ago - By: Rowley Law PLLC - Mentions: SUPN

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.

a month ago - By: Investor's Business Daily - Mentions: ACAD SLNO HRMY NBIX ...

Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity

a month ago - By: Halper Sadeh LLC - Mentions: COEP AVDX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

2 months ago - By: FN Media Group LLC - Mentions: NYSE CMPS MNMD ATAI

Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

2 months ago - By: Brodsky & Smith LLC - Mentions: VERV CTLP NYSE LLY ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

2 months ago - By: Halper Sadeh LLC - Mentions: GNTY CHTR TASK

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNTY, CHTR, SAGE, TASK on Behalf of Shareholders

2 months ago - By: Phathom Pharmaceuticals - Mentions: PHAT

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

2 months ago - By: Kahn Swick & Foti, LLC

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

2 months ago - By: Yahoo Finance - Mentions: BIIB SUPN

H.C. Wainwright sees potential competition for Sage from Biogen

2 months ago - By: Halper Sadeh LLC - Mentions: VERV CTLP SOAR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders

2 months ago - By: Brodsky & Smith LLC - Mentions: VERV CTLP SOAR LLY ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

2 months ago - By: Yahoo Finance - Mentions: AGEN HON ITGR TTEK ...

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

2 months ago - By: Yahoo Finance - Mentions: CRCL SF HNGE ATAT ...

How to get a $40,000 personal loan

2 months ago - By: Yahoo Finance - Mentions: BIIB SUPN

SAGE THERAPEUTICS INC (SAGE) Stock News

SAGE Latest News, Press Relases and Analysis

Sage (SAGE) Q2 Revenue Jumps 264%

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics

Sage Therapeutics Announces Second Quarter 2025 Financial Results

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

Beyond The Numbers: 6 Analysts Discuss Sage Therapeutics Stock

Deep Dive Into Sage Therapeutics Stock: Analyst Perspectives (4 Ratings)

ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.

Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNTY, CHTR, SAGE, TASK on Behalf of Shareholders

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

H.C. Wainwright sees potential competition for Sage from Biogen

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

How to get a $40,000 personal loan

Supernus makes depression drug play with $795m Sage buyout